Navigation Links
Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
Date:1/14/2009

partial response, as did 76 percent of patients in the FOLFOX arm, including seven patients with a partial response.

"These interim, proof-of-concept Phase 2 results are very encouraging and continue to suggest the potential of picoplatin as a neuropathy-sparing first-line therapy for metastatic colorectal cancer," said Robert De Jager, M.D., chief medical officer of Poniard. "We continue to observe the study participants to obtain progression-free and overall survival data. We expect that those data will support our primary goal of developing picoplatin as a preferred platinum therapy for patients with metastatic colorectal cancer who cannot tolerate the toxicity profile of currently marketed platinums."

About Picoplatin

Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors. It has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin has been evaluated in more than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney toxicity (nephrotoxicity) and nerve toxicity (neurotoxicity) than is commonly observed with other platinum chemotherapy drugs. It is being studied in multiple cancer indications, treatment combinations and in two formulations.

In addition to the Phase 2 clinical trial in CRC, Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as SPEAR (Study of Picoplatin Efficacy After Relapse), in small cell lung cancer. This registration trial currently is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration and is evaluating overall survival as the primary endpoint. Picoplatin is also being evaluated in an ongoing Phase 2 clinical trial in patients with metastatic hormone-refractory prostate cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors. The
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
3. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
4. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
5. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
6. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
7. Poniard Pharmaceuticals Announces Upcoming Conference Participation
8. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
11. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Bed ... that the university had already confirmed it. Meanwhile, My Cleaning ... help bed bug victims fight the pests without using harmful ... posted on May 15, 2013, the affected building was actually ... it being infested was said made on May 13 and ...
(Date:5/22/2013)... 22, 2013 Industry leaders from ... for the Oak Ridge National Laboratory’s Biosurveillance ... place at the Hilton Alexandria Mark Center. Held ... 2013 conference on June 18 - 19. ... AdSave, American Elements, Applied Research Associates, ARA, AttaGene, ...
Breaking Biology Technology:Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5
... 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a ... resignation of Ms. Chup Hung Mok from its Board ... a search for a replacement director and is considering ... in due course when it appoints a new director. ...
... Jan. 4, 2012  Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), ... diseases, announced today that it has promoted Niranjan Y. ... to Chief Operating Officer. In his expanded role, Dr. ... for the company in addition to continuing to oversee ...
... PALM BEACH, Fla., Jan. 3, 2012  The secret to the ... yard. Sponsored by Dr. Kenneth Beer, M.D. and Mrs. Kathy ... growth experts from The University of Pennsylvania School of Medicine ... January 29, 2012, residents of South Florida will have an ...
Cached Biology Technology:Sinovac Announces Resignation of Chup Hung Mok from Board of Directors 2Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 2Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 3Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 4Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 5Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging 2
(Date:5/23/2013)... Publishing in Neuron , the team reveal the ... in work funded by the Wellcome Trust and BBSRC. ... external stimuli we improve our perceptual abilities. While these ... they can also affect the fidelity of that response. ... Visual Neuroscience explains: "When you communicate with others, you ...
(Date:5/22/2013)... NEW YORK CITY, May 22, 2013 U.S. Forest ... multi-disciplinary team that, with funding from the TKF Foundation, ... spaces help communities and individuals recover from tragedy. , ... is one of six projects selected for grant funding. ... spaces and sacred spaces in recovery and resiliency, the ...
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Tests lead to doubling of fuel cell life 2
... are leading an ambitious research project to develop an ... The success of the project to create a ... the way for scientists to create completely new and ... Professor Natalio Krasnogor of the University,s School of ...
... many pharmaceutical company and university laboratories, scientists are looking ... roles in essential cell functions. By taking unusual steps ... and the National Institutes of Health have found a ... complete with a rare location on its structure that ...
... the southwestern U.S. was in the middle of a multi-decade ... drought known for this region. But it was not the ... period of more than 100 years characterized by a multi-decade ... scientists at the University of Arizona. UA geoscientists Cody ...
Cached Biology News:Easily 're-programmable cells' could be key in creation of new life forms 2Easily 're-programmable cells' could be key in creation of new life forms 3Model of enzyme's structure could spur new therapies 2UA scientists find evidence of Roman period megadrought 2UA scientists find evidence of Roman period megadrought 3UA scientists find evidence of Roman period megadrought 4
This bispecific antibody complex has been tested for efficient depletion of CD41+ cells using the StemSep ; negative immunomagnetic cell separation system....
... and rapid solutions to meet your laboratory's requirements for data management and quality control. ... ... ... CLARA® is the standard software for Staccato Systems and custom Allegro Modules allowing for ...
... by end-users to be "a delight to ... light microscopy and electronic imaging. With its ... not require much space and can easily ... The DM-BA300 combines Motic's own revolutionary Colour ...
The LAS-3000 imaging system combines new CCD camera technology with a simplified user interface to provide significantly improved system sensitivity with a wide range of modularities. This system is...
Biology Products: